CMS Open Payments · Program Year 2024
Nevada
Nevada received $27,751,673.21 in pharmaceutical-industry payments to 6,216 physicians and 11 teaching hospitals across 155,797 transactions.
- $27.8M
- Total payments
- $24.9M
- To physicians
- $716.0K
- To teaching hospitals
- #31
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $27.8M in payments to 6,216 physicians and 11 teaching hospitals in Nevada. That ranks Nevada #31 of 59 states and territories (0.2% of the US total), averaging $4.0K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
Nevada pairs below-median payment volume with an overwhelmingly physician-directed payment mix.
- #31
- of 59 states
- 0.2%
- of the national total
- 89.7%
- to physicians vs. hospitals
- 6,216
- physicians paid
What the Data Shows for Nevada
Nevada's Open Payments file is physician-weighted: 89.7% of $27.8M went to 6,216 physicians ($4.0K each), with 2.6% on 11 teaching hospitals.
Volume rank is #31 of 59: mid-pack dollars with the mix as the distinctive cut. Average transaction $178.13. Leading nature of payment: "Acquisitions" at $7.4M (26.8% of the state file; top-three natures 59.6%).
Nevada sits in the 49th percentile (lower-volume tier). Just above: Wisconsin ($30.5M). Just below: District of Columbia ($26.4M). For context: top-ranked California ($342.4M) is 12.3× larger than Nevada. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in Nevada are distributed between physicians and teaching hospitals.
Physician Payments
$24.9M
89.7% of total · 6,216 recipients · $4.0K avg
Teaching Hospital Payments
$716.0K
2.6% of total · 11 hospitals · $65.1K avg
Payment Breakdown by Type
Nevada has 15 types of pharmaceutical payments. "Acquisitions" accounts for 26.8%.
Nature concentration in Nevada
Top three Open Payments natures are 59.6% of state dollars; residual is every other reported nature
Payment categories in Nevada
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Acquisitions | $7.4M | 9 | 26.8% |
| Compensation for Services Other Than Consulting | $4.8M | 2,074 | 17.3% |
| Food and Beverage | $4.3M | 143,017 | 15.6% |
| Consulting Fee | $4.1M | 1,854 | 14.6% |
| Royalty or License | $2.3M | 123 | 8.4% |
| Travel and Lodging | $1.5M | 5,255 | 5.6% |
| Education | $860.2K | 2,496 | 3.1% |
| Debt Forgiveness | $660.8K | 63 | 2.4% |
| Long-Term Medical Supply or Device Loan | $587.8K | 156 | 2.1% |
| Compensation for Faculty or Speaker (Medical Education) | $549.1K | 153 | 2.0% |
| Honoraria | $343.9K | 116 | 1.2% |
| Grant | $115.9K | 14 | 0.4% |
| Gift | $95.4K | 333 | 0.3% |
| Space Rental or Facility Fees | $52.4K | 37 | 0.2% |
| Entertainment | $9.3K | 97 | 0.0% |
Read with this Nevada Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: Wisconsin ($30.5M)
- Next lower total: District of Columbia ($26.4M)
- Nearest physician-share mix: Vermont (90.4% to physicians)
- Nearest physician-share mix: Florida (88.8% to physicians)
- Nearest physician-share mix: Kansas (90.7% to physicians)
- National catalog for leading nature here: Acquisitions (26.8% of Nevada)
- State payment rankings (includes Nevada at #31)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What Nevada totals can and cannot tell you
The aggregate payment figure for Nevada measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.